Compare AKRO & ARHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in a number of categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and eCommerce sales channels.